Catalyst Wire Dossier Catalyst Wire Dossier

Sublingual/Oral Immunotherapy for Peanut Allergy (investigational)

· Johns Hopkins University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual/Oral Immunotherapy for Peanut Allergy (investigational), covering 2017-04-07 to 2017-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy [Phase 1, Phase 2]

See pricing